DiNuzzo Private Wealth’s Pfizer PFE Stock Holding History

DiNuzzo Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Buy	1,122 +4	+0.4%	+$105	﹤0.01%	182
2026 Q1	$31.4K	Hold	1,118	–	–	﹤0.01%	161
2025 Q4	$27.8K	Buy	1,118 +27	+2%	+$681	﹤0.01%	166
2025 Q3	$27K	Buy	1,091 +17	+2%	+$420	﹤0.01%	167
2025 Q2	$26K	Buy	1,074 +6	+0.6%	+$140	﹤0.01%	168
2025 Q1	$27.1K	Buy	1,068 +73	+7%	+$1.91K	﹤0.01%	154
2024 Q4	$26.4K	Sell	995 -321	-24%	-$8.71K	﹤0.01%	158
2024 Q3	$38.1K	Sell	1,316 -5	-0.4%	-$146	﹤0.01%	141
2024 Q2	$37K	Buy	1,321 +34	+3%	+$936	0.01%	109
2024 Q1	$35.7K	Sell	1,287 -4	-0.3%	-$111	﹤0.01%	108
2023 Q4	$37.2K	Buy	+1,291	New	+$39K	0.01%	106

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

DiNuzzo Private Wealth's PFE Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Pfizer (PFE) stake by 0.36% in Q2 2026, buying an estimated $105 and bringing the position to 1,122 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #182.

DiNuzzo Private Wealth first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $38.1K in Q3 2024. 1,091 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DiNuzzo Private Wealth held 1,122 shares of Pfizer worth $27K as of Q2 2026.
DiNuzzo Private Wealth bought 4 Pfizer shares in Q2 2026, an estimated $105.
Pfizer made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #182 holding.
DiNuzzo Private Wealth first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's Pfizer position peaked at $38.1K in Q3 2024.
1,091 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.